Antiviral restriction factor transgenesis in the domestic cat

Nature Methods

Volumn 8, Issue 10, 2011, Pages 853-859

  Wongsrikeao, Pimprapar ^a   Saenz, Dyana ^a   Rinkoski, Tommy ^a   Otoi, Takeshige ^b   Poeschla, Eric ^a  

^a Mayo Clinic   (United States)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARNIVORE; CAT; CONTROLLED STUDY; DOMESTIC ANIMAL; EMBRYO; FELINE IMMUNODEFICIENCY VIRUS; FEMALE; GAMETE; GENE EXPRESSION; GENE SILENCING; GENETIC MANIPULATION; GENETIC SUSCEPTIBILITY; LYMPHOCYTE; MACACA; MALE; MOSAICISM; NONHUMAN; PRIORITY JOURNAL; TRANSGENICS; VIRAL GENE THERAPY; VIRUS REPLICATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CATS; DISEASE MODELS, ANIMAL; FEMALE; GENE TRANSFER TECHNIQUES; IMMUNODEFICIENCY VIRUS, FELINE; LYMPHOCYTES; MALE; VIRUS REPLICATION;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; MACACA MULATTA; MAMMALIA;

EID: 80053358339     PISSN: 15487091     EISSN: 15491676     Source Type: Journal    
DOI: 10.1038/nmeth.1703     Document Type: Article

References (40)

1. Menotti-Raymond, M. & O'Brien, S.J. The domestic cat, Felis catus, as a model of hereditary and infectious disease. in Sourcebook of Models for Biomedical Research (ed., Conn, P.M.) 221-232 (Humana Press, 2008).
2. O'Brien, S.J. et al. State of cat genomics. Trends Genet. 24, 268-279 (2008).
3. Meli, M.L. et al. Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus). PLoS ONE 4, e4744 (2009).
4. Willett, B.J. et al. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71, 6407-6415 (1997). (Pubitemid 27355294)
5. Llano, M. et al. An essential role for LEDGF/p75 in HIV integration. Science 314, 461-464 (2006). (Pubitemid 44628966)
6. Huthoff, H. & Towers, G.J. Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha. Trends Microbiol. 16, 612-619 (2008).
7. Saenz, D.T., Teo, W., Olsen, J.C. & Poeschla, E. Restriction of feline immunodeficiency virus by Ref1, LV1 and primate TRIM5a proteins. J. Virol. 79, 15175-15188 (2005). (Pubitemid 43032300)
8. Wilson, S.J. et al. Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc. Natl. Acad. Sci. USA 105, 3557-3562 (2008). (Pubitemid 351723591)
9. Münk, C. et al. Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol. 9, R48 (2008).
10. Stern, M.A. et al. Productive replication of Vif-chimeric HIV-1 in feline cells. J. Virol. 84, 7378-7395 (2010).
11. McEwan, W.A. et al. Truncation of TRIM5 in Feliformia explains the absence of retroviral restriction in cells of the domestic cat. J. Virol. 16, 8270-8275 (2009).
12. Dietrich, I. et al. Potent lentiviral restriction by a synthetic feline TRIM5 cyclophilin A fusion. J. Virol. 84, 8980-8985 (2010).
13. Neagu, M.R. et al. Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. J. Clin. Invest. 119, 3035-3047 (2009).
14. Yin, X.J. et al. Generation of cloned transgenic cats expressing red fluorescence protein. Biol. Reprod. 78, 425-431 (2008).
15. Gomez, M.C. et al. Generation of domestic transgenic cloned kittens using lentivirus vectors. Cloning Stem Cells 11, 167-176 (2009).
16. Meissner, A. & Jaenisch, R. Mammalian nuclear transfer. Dev. Dyn. 235, 2460-2469 (2006). (Pubitemid 44325260)
17. Yamanaka, S. & Blau, H.M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 465, 704-712 (2010).
18. Pfeifer, A. Lentiviral transgenesis-a versatile tool for basic research and gene therapy. Curr. Gene Ther. 6, 535-542 (2006). (Pubitemid 44194394)
19. Richardson, M.W. et al. Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha. J. Virol. 82, 11117-11128 (2008).
20. Lyall, J. et al. Suppression of avian influenza transmission in genetically modified chickens. Science 331, 223-226 (2011).
21. Lim, S.Y. et al. TRIM5alpha modulates immunodeficiency virus control in Rhesus monkeys. PLoS Pathog. 6, e1000738 (2010).
22. Bieniasz, P.D. & Cullen, B.R. Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J. Virol. 74, 9868-9877 (2000).
23. Hubel, D.H. & Wiesel, T.N. Receptive fields, binocular interaction and functional architecture in the cat's visual cortex. J. Physiol. (Lond.) 160, 106-154 (1962).
24. Hubel, D.H. & Wiesel, T.N. The period of susceptibility to the physiological effects of unilateral eye closure in kittens. J. Physiol. (Lond.) 206, 419-436 (1970).
25. Blakemore, C. & Van Sluyters, R.C. Innate and environmental factors in the development of the kitten's visual cortex. J. Physiol. (Lond.) 248, 663-716 (1975).
26. Blakemore, C., Van Sluyters, R.C., Peck, C.K. & Hein, A. Development of cat visual cortex following rotation of one eye. Nature 257, 584-586 (1975).
27. Douglas, R.J. & Martin, K.A. Neuronal circuits of the neocortex. Annu. Rev. Neurosci. 27, 419-451 (2004). (Pubitemid 39050409)
28. Sasaki, E. et al. Generation of transgenic non-human primates with germline transmission. Nature 459, 523-527 (2009).
29. Yang, S.H. et al. Toward a transgenic model of Huntington's disease in a non-human primate. Nature 453, 921-924 (2008).
30. Holt, N. et al. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat. Biotechnol. 28, 839-847 (2010).
31. Pineda, M.H. Reproductive patterns of cats. in McDonald's Veterinary Endocrinology and Reproduction (eds. Pineda, M.H. & Dooley, M.P.) 505-522 (Iowa State Press, 2003).
32. Leyva, H., Madley, T. & Stabenfeldt, G.H. Effect of light manipulation on ovarian activity and melatonin and prolactin secretion in the domestic cat. J. Reprod. Fertil. Suppl. 39, 125-133 (1989).
33. Wood, T.C. & Wildt, D.E. Effect of the quality of the cumulus-oocyte complex in the domestic cat on the ability of oocytes to mature, fertilize and develop into blastocysts in vitro. J. Reprod. Fertil. 110, 355-360 (1997).
34. Loewen, N. & Poeschla, E.M. Lentiviral vectors. Adv. Biochem. Eng. Biotechnol. 99, 169-191 (2005). (Pubitemid 44617181)
35. Saenz, D.T., Barraza, R., Loewen, N., Teo, W. & Poeschla, E. Production and Use of Feline Immunodeficiency Virus (FIV)-based lentiviral vectors. in Gene Transfer: A Cold Spring Harbor Laboratory Manual (eds. Rossi, J. & Friedman, T.) 57-74 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2006).
36. Miest, T., Saenz, D., Meehan, A., Llano, M. & Poeschla, E.M. Intensive RNAi with lentiviral vectors in mammalian cells. Methods 47, 298-303 (2009).
37. Szymczak, A.L. & Vignali, D.A. Development of 2A peptide-based strategies in the design of multicistronic vectors. Expert Opin. Biol. Ther. 5, 627-638 (2005). (Pubitemid 40780547)
38. Amendola, M., Venneri, M.A., Biffi, A., Vigna, E. & Naldini, L. Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. Nat. Biotechnol. 23, 108-116 (2005). (Pubitemid 41724633)
39. Talbott, R.L. et al. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86, 5743-5747 (1989). (Pubitemid 19217531)
40. Poeschla, E., Wong-Staal, F. & Looney, D. Efficient transduction of nondividing cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4, 354-357 (1998). (Pubitemid 28144098)